Econazole, an antifungal drug used to treat a variety of superficial fungal infections such as tinea infections, cutaneous candidiasis, and pityriasis versicolor, was developed in the 1970s and introduced for medical use in the early 1980s. It belongs to the imidazole class of antifungals and works by inhibiting ergosterol synthesis, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. Econazole is primarily used as a topical formulation (cream, lotion, or solution) and is applied directly to affected skin areas, making it effective for localized infections with minimal systemic absorption. Its development contributed to the expansion of topical azole therapies, offering broad-spectrum activity against dermatophytes, yeasts, and some Gram-positive bacteria, and it remains a widely used and well-established option in dermatologic antifungal treatment.
BRAND NAMES
Pevaryl / Pevisone (used in some regions, often in combination formulations with corticosteroids)
Econazole nitrate cream/lotion (generic branded versions under various manufacturers).
MECHANISM OF ACTION
Econazole is an imidazole antifungal that works by inhibiting the fungal enzyme 14-α-demethylase (a cytochrome P450–dependent enzyme), which is essential for the synthesis of ergosterol, a key structural component of fungal cell membranes. By blocking ergosterol production, econazole disrupts the integrity and permeability of the fungal cell membrane, leading to leakage of cellular contents and inhibition of fungal growth.
PHARMACODYNAMICS
Econazole exerts its pharmacodynamic effect by disrupting fungal cell membrane synthesis through inhibition of the enzyme 14-α-demethylase, a cytochrome P450–dependent enzyme required for converting lanosterol to ergosterol. Ergosterol is an essential structural component of fungal cell membranes, and its depletion leads to increased membrane permeability, impaired membrane-bound enzyme function, and leakage of intracellular contents.
ADMINISTRATION
Econazole is administered topically for the treatment of superficial fungal infections of the skin. It is available mainly as a cream, lotion, or solution, and is applied directly to the affected area after cleaning and drying the skin.
DOSAGE AND STRENGTH
Econazole is available in topical formulations, most commonly as a 1% (10 mg/g or 10 mg/mL) preparation in the form of cream, lotion, or solution. This standard strength is used for the treatment of superficial fungal infections of the skin, including dermatophytosis and cutaneous candidiasis.
DRUG INTERACTIONS
Econazole has minimal clinically significant drug–drug interactions because it is primarily used topically and shows very low systemic absorption. However, when a small amount is absorbed into the bloodstream, it may theoretically interact with drugs metabolized by hepatic cytochrome P450 enzymes, particularly CYP3A4, due to its inhibitory potential on these pathways.
CONTRAINDICATIONS
Econazole is contraindicated in patients with a known hypersensitivity to econazole, other imidazole antifungal agents, or any component of the formulation. It should not be used on patients who have previously experienced severe allergic reactions such as contact dermatitis, rash, or angioedema related to the drug.
SIDE EFFECTS
Skin irritation
Burning sensation at application site
Itching (pruritus)
Redness (erythema)
Stinging or tingling sensation
Dry skin.
OVER DOSAGE
Econazole overdose is very rare due to its topical route of administration and minimal systemic absorption. Even when applied in excessive amounts, most of the drug remains localized in the skin and does not reach significant systemic levels. However, inappropriate or prolonged overuse may lead to increased local adverse effects such as skin irritation, burning, redness, itching, or contact dermatitis.
TOXICITY
Econazole toxicity is rare because it is primarily used as a topical antifungal agent with minimal systemic absorption. When toxicity does occur, it is usually limited to local skin reactions resulting from excessive or prolonged use, such as severe irritation, erythema, burning, itching, or allergic contact dermatitis.
